The authors discuss the role of interferon-gamma (IFN-γ) in the response of melanoma patients to immune checkpoint inhibitors (ICIs) with respect to its positive influence and role in IFN-γ-related mechanisms of resistance to ICIs.
[Molecular Cancer]